AlphaYou
Overview
Smart-money signal on BDX this 14d.
Key stats
Sep 6- Open
- $185.42
- 52-wk high
- $193.07
- High
- $187.13
- 52-wk low
- $125.21
- Low
- $184.05
- Prev close
- $187.62
- Mkt cap
- $50.32B
- P/E
- 32.0x
- Volume
- 1.44M
- Fwd P/E
- 14.1x
- Beta
- 0.28
- Div yield
- 2.23%
- P/S
- 2.2x
- P/B
- 2.1x
- Profit margin
- +4.2%
- Op margin
- +15.7%
- ROE
- +6.6%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Earnings
Earnings came in 12.9% below what analysts expected.
Earnings per share
$3.33 expected
Revenue
$4.89B expected
Company adjusted EPS
From the company's release
The company and the analyst consensus count earnings differently, so the two figures differ. The comparison above uses the analyst basis.
GAAP EPS was $1.64 and adjusted EPS was $3.23. The adjusted figure is comparable to consensus.
What the street expects next
EPS expected
$4.03 to $4.11
Revenue expected
11 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.89B | $5.25B | $4.71B | $4.98B |
| Cost of what it sold | $3.09B | $2.91B | $2.56B | $2.67B |
| Gross profit | $2.80B | $2.34B | $2.15B | $2.31B |
| What it spent | ||||
| Research and development | $322.0M | $318.0M | $249.0M | $258.0M |
| Sales and admin | $1.37B | $1.43B | $1.21B | $1.26B |
| Other operating costs | $414.0M | — | $599.0M | $133.0M |
| Total operating expenses | $2.10B | $1.75B | $2.06B | $1.65B |
| What was left | ||||
| Operating profit | $697.0M | $594.0M | $94.0M | $663.0M |
| Interest on debt | $155.0M | $107.0M | $149.0M | $132.0M |
| Profit before tax | $510.0M | $487.0M | $39.0M | $554.0M |
| Tax | $17.0M | $105.0M | $76.0M | $103.0M |
| Net profit | $493.0M | $382.0M | -$311.0M | $377.0M |
| EBITDA | $1.29B | $1.21B | $709.0M | $686.0M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Becton Dickinson (NYSE: BDX) CFO reports 190-share tax withholding
NeutralSep 4USI Named a Top-Rated Provider of the BD® PureWick® Urine Collection System with 99.87% Patient Satisfaction Rate
NeutralSep 1Two Recessions Couldn’t Stop These 4 Healthcare Stocks From Raising Dividends
BullishAug 31Gartner Research: Healthcare Supply Chain Leaders Must Transition to Self-Managing AI Inventory Rooms
Leans bullishAug 28BD to Present at Wells Fargo 21st Annual Healthcare Conference
NeutralAug 27BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation
BullishAug 27Becton Dickinson Reaches 50% Enrollment in Breast Surgery Trial
Leans bullishAug 27BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation
BullishAug 27
Macro
20 macro signals shaping BDX right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results